Preparation of Virosomes Coated with the Vesicular Stomatitis Virus Glycoprotein As Efficient Gene Transfer Vehicles for Animal Cells

Microbiology and Immunology

Volumn 48, Issue 3, 2004, Pages 163-174

  Shoji, Jun'ichi ^a   Tanihara, Yuko ^a   Uchiyama, Tsuneo ^b   Kawai, Akihiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Gene transfer vehicle; Glycoprotein; Vesicular stomatitis virus (VSV); Virosome

Indexed keywords

ANTISERUM; CHOLESTEROL; DRUG VEHICLE; LIPID; LIPOFECTAMINE; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PLASMID DNA; SUCROSE; UNCLASSIFIED DRUG; VIROSOME; VIRUS GLYCOPROTEIN; VSV G PROTEIN VIROSOME;

ANIMAL CELL CULTURE; ARTICLE; BINDING AFFINITY; DRUG COATING; DRUG MIXTURE; ENCAPSULATION; FILTRATION; FREEZING; GENE TRANSFER; GENETIC TRANSFECTION; MEMBRANE FUSION; MOLECULAR RECOGNITION; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; PROTEIN TRANSPORT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SYNTHESIS; THAWING; ULTRACENTRIFUGATION; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE;

ANIMALIA; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 1642545236     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03502.x     Document Type: Article

References (17)

1. Abe, A., Miyanohara, A., and Friedmann, T. 1998. Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein. J. Virol. 72: 6159-6163.
2. Baum, C., Dullmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D.A., and von Kalle, C. 2003. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101: 2099-2114.
3. Cichon, G., Boeckh-Herwig, S., Schmidt, H.H., Whenes, E., Mueller, T., and Pring-Akerblom, P. 2001. Complement activation by recombinant adenoviruses. Gene Ther. 8: 1794-1800.
4. Connolly, J.B. 2002. Lentiviruses in gene therapy clinical research. Gene Ther. 9: 1730-1734.
5. Gore, M.E. 2003. Gene therapy can cause leukaemia: no shock, mild horror but a probe. Gene Ther. 10: 4-4.
6. Gray, D.A. 1991. Insertional mutagenesis: neoplasia arising from retroviral integration. Cancer Invest. 9: 295-304.
7. Imazu, S., Nakagawa, S., Nakanishi, T., Mizuguchi, H., Uemura, H., Yamada, O., and Mayumi, T. 2000. A novel nonviral vector based on vesicular stomatitis virus. J. Control. Release 68: 187-194.
8. Kaneda, Y. 2002. Viral liposomes, p. 63-72. In Morgan, J.R. (ed), Gene therapy protocols, 2nd ed, Chapter 5, Humana Press, Totowa.
9. Kawai, A. 1977. Transcriptase activity associated with rabies virion. J. Virol. 24: 826-835.
10. Laemmli, U.K. 1970. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
11. Machia, C.A. (ed), 2003. Viral vectors for gene therapy, Methods and protocols, Humana Press, Totowa.
12. Maulik, S., and Patel, S.D. 1997. Human gene therapy, p. 37-67. In Molecular biotechnology: therapeutic applications and strategies, Chapter 2, Wiley-Lyss, Inc., New York.
13. Morgan, J.R. (ed), 2002. Gene therapy protocols, 2nd ed, Humana Press, Totowa.
14. Powell, S.K., Kaloss, M., Burimski, I., Weaver, L., Long, Z., Lyons, R., McGarrity, G.J., and Otto, E. 1999. In vitro analysis of transformation potential associated with retroviral vector insertions. Hum. Gene Ther. 10: 2123-2132.
15. Scully, S.P. 2000. Gene therapy: clinical considerations. Clin. Orthop. 379 (Suppl): S55-58.
16. St. George, J.A. 2003. Gene therapy progress and prospects: adenoviral vectors. Gene Ther. 10: 1135-1141.
17. Superti, F., Seganti, L., Ruggeri, F.M., Tinari, A., Donelli, G., and Orsi, N. 1987. Entry pathway of vesicular stomatitis virus into different host cells. J. Gen. Virol. 68: 387-399.